Incisive Genetics

About:

Incisive Genetics is developing a delivery platform for genetic therapies.

Website: https://www.incisivegenetics.com/

Top Investors: entrepreneurship@UBC, Haig Farris, Noel Hall, Sandra MacPherson

Description:

IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Total Funding Amount:

$2.88M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2018-01-01

Contact Email:

info(AT)incisivegenetics.com

Founders:

Austin Hill, Blair Leavitt, Pamela Wagner

Number of Employees:

1-10

Last Funding Date:

2021-07-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai